Profit with us in the 2009 bear market
Research Report
Hotstocked.com has a complete research report available for DNDN stock. Download DNDN report.
Research Report
Get the full report for FREE
Date:Aug 12, 2009
Price:Free
Pages:5
Document Type:Adobe Acrobat Reader
 Download DNDN report
  
Example preview: Research report for Dendreon Co (DNDN) Research report for Dendreon Co (DNDN) Research report for Dendreon Co (DNDN) Research report for Dendreon Co (DNDN)
   

Profile for Dendreon Co (DNDN)

Markets Quote Depth/LII Options Charts News Company Financials Insiders Filings Analyst Earnings Historical
Profile ·  Share Information ·  Key Ratios
Symbol:  | Recent Quotes powered by
  quotemedia.com
Profile for Dendreon Corp.  (DNDN) 
$ 28.01   -0.04 (-0.14%) Volume: 2.72 m 4:00 PM EST Nov 20, 2009
After Hours:  $ 28.00   -0.01 (-0.04%) Volume: 14.26 k 7:47 PM EST Nov 20, 2009
Business Description:
A biotechnology company, which is focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.
Address: 3005 First Avenue, Seattle, WA 98121
Telephone: (206) 256-4545 Website: www.dendreon.com
Facsimile: (206) 256-0571 Email: ir@dendreon.com
Details
CEO: Dr. Mitchell H. Gold, M.D.
Employees: 198 MarketCap: 3.25 b
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: UQ
Indices: Biotechnology , DJ US Biotechnology , Russell 1000
Industry Classifications
Sector: Healthcare CIK: 0001107332
Industry: Drugs
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)

Copyright © QuoteMedia.   Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).   RT   Realtime,  DL+   Realtime BATS,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia, profiles by Morningstar.  Terms of Use. 
   
 
Home > Companies > Dendreon Co